Investigation of developmental toxicity and teratogenicity of macrolide antibiotics in cultured rat embryos

Journal of Veterinary Medicine Series C: Anatomia Histologia Embryologia

Volumn 37, Issue 5, 2008, Pages 369-375

  Karabulut, A K ^a   Uysal, I I ^a   Acar, H ^a   Fazliogullari, Z ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; MACROLIDE;

ANIMAL; ANIMAL EMBRYO; ARTICLE; CONGENITAL MALFORMATION; CULTURE TECHNIQUE; DOSE RESPONSE; DRUG EFFECT; FEMALE; MALE; METHODOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; RANDOMIZATION; RAT; WISTAR RAT;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; ANTI-BACTERIAL AGENTS; CULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; FEMALE; MACROLIDES; MALE; PREGNANCY; RANDOM ALLOCATION; RATS; RATS, WISTAR;

RATTUS;

EID: 51249113020     PISSN: 03402096     EISSN: 14390264     Source Type: Journal    
DOI: 10.1111/j.1439-0264.2008.00861.x     Document Type: Article

References (30)

1. Amacher, D. E., J. H. Ellis Jr., A. J. Joyce, P. A. Muehlbauer, G. N. Turner, M. G. Wahrenburg, H. E. Holden V. A. Ray, 1993 : Preclinical toxicology studies with azithromycin: genetic toxicology evaluation. Mutat. Res. 300, 79 90.
2. Amsden, G. W., 1996 : Erithromycin, clarithromycin, and azithromycin: are differences real?. Clin. Ther. 18, 56 72.
3. Blondeau, J. M., E. DeCarolis, K. L. Metzler G. T. Hansen, 2002 : The macrolides. Expert Opin. Investig. Drugs 11, 189 215.
4. Bothe, R., J. M. van't Wout, S. Lobatto, A. Blusse van Oud Alblas, M. Boekhout, E. H. Nauta, J. Hermas P. J. van den Broek, 1995 : Efficacy and safety of azithromycin in community acquired pneumonia. Eur. J. Clin. Microbiol. Infect. Dis. 14, 182 187.
5. Drinkard, C. R., D. Shatin J. Clouse, 2000 : Postmarketing surveillance of medications and pregnancy outcomes: clarithromycin and birth malformations. Pharmacoepidemiol. Drug Saf. 9, 549 556.
6. Einarson, A., E. Phillips, F. Mawji, D. D'Alimonte, B. Schick A. Addis, 1998 : A prospective controlled multicentre study of clarithromycin in pregnancy. Am. J. Perinatol. 15, 523 525.
7. Feldman, C., R. Anderson, A. J. Theron, G. Ramafi, P. J. Cole R. Wilson, 1997 : Roxithromycin, clarithromycin, and azithromycin attenuate the injurious effects of bioactive phospholipids on human respiratory epithelium in vitro. Inflammation 21, 655 665.
8. Foulon, W., I. Villena, B. Stray-Pedersen, A. Decoster, M. Lappalainen, J. M. Pinon, P. A. Jenum, K. Hedman A. Naessens, 1999 : Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at 1 year. Am. J. Obstet. Gynecol. 180, 410 415.
9. Goldman, M. P. D. L. Longworth, 1993 : The role of azithromycin and clarithromycin in clinical practice. Cleve. Clin. J. Med. 60, 359 364.
10. Gratzl, R., G. Sodeck, P. Platzer, W. Jager, J. Graf, A. Pollak T. Thalhammer, 2002 : Treatment of toxoplasmosis in pregnancy: concentrations of spiramycin and neospiramycin in maternal serum and amniotic fluid. Eur. J. Clin. Microbiol. Infect. Dis. 21, 12 16.
11. King, A., T. Bathgate I. Phillips, 2002 : Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin. Clin. Microbiol. Infect. 8, 85 92.
12. Kolialexi, A., G. T. Tsangaris, A. Antsaklis, F. Tzortzatou, C. Amentas, A. Koratzis A. Mavrou, 2001 : Apoptosis in maternal peripheral blood during pregnancy. Fetal Diagn. Ther. 16, 32 37.
13. Korzeniowski, O. M., 1995 : Antibacterial agents in pregnancy. Infect. Dis. Clin. North Am. 9, 639 651.
14. Lakhssassi, N. M. Sixou, 2005 : Efficacy variation of erithromycin and spiramycin on priopathogens in aggressive periodontitis. An in vitro comparative study. Pathol. Biol. (Paris) 53, 527 535 (Abstract).
15. Maele, G. V., F. F. Delhaise J. J. Picard, 1990 : Morphogenesis and quantification of the development of post-implantation mouse embriyos. Toxicol. In Vitro 4, 149 156.
16. Many, A. G. Koren, 2006 : Toxoplasmosis during pregnancy. Can. Fam. Physician 52, 29 30.
17. Miller, J. M. D. H. Martin, 2000 : Treatment of Chlamydia trachomatis infections in pregnant women. Drugs 60, 597 605.
18. New, D. A. T., 1978 : Whole embriyo culture and the study of mammalian embriyos during organogenesis. Biol. Rev. 53, 81 122.
19. Ohtani, H., C. Taninaka, E. Hanada, H. Kotaki, H. Sato, Y. Sawada T. Iga, 2000 : Comparative pharmacodynamic analysis of Q-T interval prolongation induced by the macrolidesclarithromycin, roxithromycin, and azithromycin in rats. Antimicrob. Agents Chemother. 44, 2630 2637.
20. Periti, P., T. Mazzei, E. Mini A. Novelli, 1993 : Advers effects of macrolide antibacterials. Drug Saf. 9, 346 364.
21. Ramsey, P. S., M. B. Vaules, G. M. Vasdev, W. W. Andrews K. D. Ramin, 2003 : Maternal and transplacental pharmacokinetics of azithromycin. Am. J. Obstet. Gynecol. 188, 714 718.
22. Rouveix, B., M. Levacher J. P. Giroud, 1999 : Drugs for respiratory tropism and pregnancy. Rev. Pneumol. Clin. 55, 338 343 (Abstract).
23. Rubinstein, E., 2001 : Comparative safety of the different macolides. Int. J. Antimicrob. Agents 18, 71 76.
24. Sa del Fiol, F., M. Gerenutti F. C. Groppo, 2005 : Antibiotics and pregnancy. Pharmazie 60, 483 493.
25. Shiba, K., 2000 : Pharmacokinetics and tissue distribution of azithromycin in humans. Jpn. J. Antibiot. 53 (Suppl. B 43 59 (Abstract).
26. Stein, G. E. D. H. Havlichek, 1992 : The new macrolide antibiotics. Azithromycin and clarithromycin. Postgrad. Med. 92, 269 272.
27. Stray-Pedersen, B., 1993 : Toxoplasmosis in pregnancy. Bailieres Clin. Obstet. Gynecol. 7, 107 137.
28. Viluksela, M., P. J. Vainio R. K. Tuominen, 1996 : Cytotoxicity of macrolide antibiotics in a cultured human liver cell line. Antimicrob. Chemother. 38, 465 473.
29. Weber, J. T. R. E. Johnson, 1995 : New treatments for Chlamydia trachomatis genital infection. Clin. Infect. Dis. 20 (Suppl. 1 66 71.
30. Zhanel, G. G., M. Dueck, D. J. Hoban, L. M. Vercaigne, J. M. Embil, A. S. Gin J. A. Korlowsky, 2001 : Review of macrolides and ketolides: focus on respiratory tract infections. Drugs 61, 443 498.